Neuren Pharmaceuticals | NEU - Operating Expenses



Neuren Pharmaceuticals reported AUD17.41M in Operating Expenses for its fiscal semester ending in December of 2024.


Operating Expenses Change Date
Alaunos Therapeutics USD 759K 391K Dec/2024
Avita Medical AUD 28.36M 2.44M Dec/2024
Clinuvel Pharmaceuticals AUD 20.71M 2.35M Jun/2024
Dianthus Therapeutics USD 35.12M 1.88M Jun/2025
Genetic Signatures AUD 24.53M 8.13M Dec/2024
Ionis Pharmaceuticals USD 312.21M 34.21M Jun/2025
Medical Developments International AUD 19.8M 9.46M Dec/2024
Neuren Pharmaceuticals AUD 17.41M 2.86M Dec/2024
Organon & Co USD 1.27B 144M Jun/2025
Paradigm Biopharmaceuticals AUD 6.36M 8.6M Dec/2024
PYC Therapeutics AUD 38.58M 20.29M Dec/2024
Starpharma Holdings AUD 7.82M 3.39M Dec/2024
Tectonic Therapeutic USD 22.33M 8.34M Jun/2025
Telix Pharmaceuticals AUD 191.9M 130.08M Dec/2024
Viatris USD 3.4B 2.88B Jun/2025
Xeris Pharmaceuticals USD 67.06M 8.64M Jun/2025